Jessie Wang

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis

Xiaoli Wang, Giridhar Tirucherai, Thomas Marbury et al. · The Journal of Clinical Pharmacology · 2015 · 280 citations · Full text

Healthy Subjects, Dialysis Therapy, Pharmacotherapy +19

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor<scp>X</scp>a inhibitor, in healthy subjects

Charles Frost, Sunil Nepal, Jessie Wang et al. · British Journal of Clinical Pharmacology · 2013 · 277 citations · Full text

Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects

Vijay Upreti, Jessie Wang, Yu Chen Barrett et al. · British Journal of Clinical Pharmacology · 2013 · 268 citations · Full text

Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban

Ming Chang, Zhigang Yu, Andrew Shenker et al. · The Journal of Clinical Pharmacology · 2015 · 171 citations

Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study

Jeffrey S. Hyams, Sonia Thomas, Nathan Gotman et al. · The Lancet · 2019 · 161 citations · Full text

Paediatric Colitis Therapy, Biological Predictors, Pediatric Epidemiology +9